Viridian Therapeutics, Inc.\DE short interest in 2024
In 2024, Viridian Therapeutics, Inc.\DE's disclosed short interest ran from 15.41% of shares outstanding on 12 Jan 2024 to 15.21% on 31 Dec 2024, a change of -0.20 percentage points. The year's high was 18.50% on 15 Apr 2024 and its low 11.05% on 29 Nov 2024, averaging 14.65% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.09 days on 31 Oct 2024. Full history: Viridian Therapeutics, Inc.\DE.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 15.41% (12 Jan 2024)
- End of year
- 15.21% (31 Dec 2024)
- Change
- -0.20 pp
- High
- 18.50% (15 Apr 2024)
- Low
- 11.05% (29 Nov 2024)
- Average
- 14.65%
- Highest days to cover
- 14.09 (31 Oct 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 15.41% | 8.83 | |
| 31 Jan 2024 | 16.02% | 8.39 | results (8-K) |
| 15 Feb 2024 | 14.73% | 9.24 | |
| 29 Feb 2024 | 14.40% | 8.76 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 14.49% | 6.61 | |
| 28 Mar 2024 | 18.01% | 9.36 | |
| 15 Apr 2024 | 18.50% | 13.66 | |
| 30 Apr 2024 | 17.71% | 11.55 | |
| 15 May 2024 | 15.36% | 11.60 | 10-Q filed, results (8-K) |
| 31 May 2024 | 15.12% | 10.46 | |
| 14 Jun 2024 | 14.72% | 9.26 | |
| 28 Jun 2024 | 12.40% | 5.16 | |
| 15 Jul 2024 | 13.52% | 11.24 | |
| 31 Jul 2024 | 13.30% | 6.98 | |
| 15 Aug 2024 | 12.52% | 10.28 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 12.57% | 12.14 | |
| 13 Sep 2024 | 16.37% | 2.57 | |
| 30 Sep 2024 | 15.89% | 6.39 | |
| 15 Oct 2024 | 15.33% | 11.23 | |
| 31 Oct 2024 | 15.68% | 14.09 | |
| 15 Nov 2024 | 11.48% | 6.56 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 11.05% | 8.75 | |
| 13 Dec 2024 | 11.81% | 8.69 | |
| 31 Dec 2024 | 15.21% | 5.36 |
See also: Viridian Therapeutics, Inc.\DE's full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.